Works matching DE "PATHOLOGIC complete response"
Results: 327
Highlights from the San Antonio Breast Cancer Symposium 2024.
- Published in:
- 2025
- By:
- Publication type:
- Letter
Neoadjuvant Camrelizumab for Triple-Negative Breast Cancer.
- Published in:
- 2025
- By:
- Publication type:
- Editorial
A Systematic Review of Disappearing Colorectal Liver Metastases: Resection or No Resection?
- Published in:
- Journal of Clinical Medicine, 2025, v. 14, n. 4, p. 1147, doi. 10.3390/jcm14041147
- By:
- Publication type:
- Article
Predicting the efficacy of neoadjuvant chemotherapy in breast cancer patients based on ultrasound longitudinal temporal depth network fusion model.
- Published in:
- Breast Cancer Research, 2025, v. 27, n. 1, p. 1, doi. 10.1186/s13058-025-01971-5
- By:
- Publication type:
- Article
Combined morphology and radiomics of intravoxel incoherent movement as a predictive model for the pathologic complete response before neoadjuvant chemotherapy in patients with breast cancer.
- Published in:
- Frontiers in Oncology, 2025, p. 1, doi. 10.3389/fonc.2025.1452128
- By:
- Publication type:
- Article
Case report: Patients with positive HER-2 amplification locally advanced gastroesophageal junction cancer achieved pathologic complete response with the addition of pembrolizumab to chemotherapy plus trastuzumab as neoadjuvant therapy.
- Published in:
- Frontiers in Immunology, 2025, p. 1, doi. 10.3389/fimmu.2025.1555074
- By:
- Publication type:
- Article
Evaluating the Efficacy of Probiotics on Disease Progression, Quality of Life, and Nutritional Status Among Patients with Crohn's Disease: A Multicenter, Randomized, Single-Blinded Controlled Trial.
- Published in:
- Nutrients, 2025, v. 17, n. 4, p. 708, doi. 10.3390/nu17040708
- By:
- Publication type:
- Article
Magnetic Resonance Elastography of Invasive Breast Cancer: Evaluating Prognostic Factors and Treatment Response.
- Published in:
- Tomography: A Journal for Imaging Research, 2025, v. 11, n. 2, p. 18, doi. 10.3390/tomography11020018
- By:
- Publication type:
- Article
Breast Cancer Patients Receiving Neoadjuvant Chemotherapy: Clinical, Pathological and Survival Characteristics and Factors Predicting Complete Response.
- Published in:
- Eurasian Journal of Medical Investigation, 2024, v. 8, n. 3, p. 173, doi. 10.14744/ejmi.2024.69932
- By:
- Publication type:
- Article
Effect of Inflammatory Markers on the Pathologic Complete Response in the Neoadjuvan Treatment of HER-2 Positive Local Advanced Breast Cancer.
- Published in:
- Eurasian Journal of Medical Investigation, 2022, v. 6, n. 4, p. 417, doi. 10.14744/ejmi.2022.65683
- By:
- Publication type:
- Article
3-year invasive disease-free survival with chemotherapy de-escalation using an <sup>18</sup>F-FDG-PET-based, pathological complete response-adapted strategy in HER2-positive early breast cancer (PHERGain).
- Published in:
- Breast Cancer Research Review, 2024, n. 44, p. 4
- By:
- Publication type:
- Article
Pathologie Response Rates in Patients with Gastric Cancer Following FLOT Neoadjuvant Chemotherapy.
- Published in:
- International Journal of Cancer Management, 2024, v. 17, n. 1, p. 1, doi. 10.5812/ijcm-139026
- By:
- Publication type:
- Article
Comparison of radiomics-based machine-learning classifiers for the pretreatment prediction of pathologic complete response to neoadjuvant therapy in breast cancer.
- Published in:
- PeerJ, 2024, p. 1, doi. 10.7717/peerj.17683
- By:
- Publication type:
- Article
Metaplastic Breast Cancer: Epidemiology, Prognosis, And Response To Neoadjuvant Therapy.
- Published in:
- Surgical Chronicles, 2023, v. 28, n. 1, p. 40
- By:
- Publication type:
- Article
Deep-learning based discrimination of pathologic complete response using MRI in HER2-positive and triple-negative breast cancer.
- Published in:
- Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-74276-w
- By:
- Publication type:
- Article
Optimal management of breast cancer with physical exam negative/radiological abnormal axilla.
- Published in:
- Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-70874-w
- By:
- Publication type:
- Article
Efficacy and prognosis of HER2-Low and HER2-Zero in triple-negative breast cancer after neoadjuvant chemotherapy.
- Published in:
- Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-67795-z
- By:
- Publication type:
- Article
Multiparametric MRI–based radiomic models for early prediction of response to neoadjuvant systemic therapy in triple-negative breast cancer.
- Published in:
- Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-66220-9
- By:
- Publication type:
- Article
Analysis of the short-term efficacy of 2 versus 3 cycles of neoadjuvant immunotherapy combined with chemotherapy in patients with esophageal squamous cell carcinoma.
- Published in:
- Journal of Cancer, 2025, v. 16, n. 1, p. 279, doi. 10.7150/jca.102215
- By:
- Publication type:
- Article
IFI27 enhances bladder cancer immunotherapy response by modulating regulatory T cell enrichment.
- Published in:
- Journal of Cancer, 2024, v. 15, n. 20, p. 6616, doi. 10.7150/jca.99014
- By:
- Publication type:
- Article
Clinicopathologic Features of 2018 American Society of Clinical Oncology/College of American Pathologists Fluorescence In Situ Hybridization Group 3 Breast Carcinoma (Human Epidermal Growth Factor Receptor 2 Chromosome 17 Centromere Ratio <2.0 and Average Human Epidermal Growth Factor Receptor 2 Copy Number ≥6.0).
- Published in:
- Archives of Pathology & Laboratory Medicine, 2024, v. 148, n. 8, p. 890, doi. 10.5858/arpa.2023-0275-OA
- By:
- Publication type:
- Article
Necessity of applying anatomical unit resection surgery in suspected posterior oral squamous cell carcinoma.
- Published in:
- BMC Oral Health, 2025, v. 25, n. 1, p. 1, doi. 10.1186/s12903-025-05572-8
- By:
- Publication type:
- Article
Extranodal natural killer/T-cell lymphoma with tonsil involvement: a case report.
- Published in:
- BMC Oral Health, 2024, v. 24, n. 1, p. 1, doi. 10.1186/s12903-024-04452-x
- By:
- Publication type:
- Article
Gastric pouch cancer after mini gastric bypass surgery: The first case report.
- Published in:
- 2024
- By:
- Publication type:
- Case Study
Fasting plasma glucose and body mass index as predictors of neoadjuvant chemotherapy response in breast cancer.
- Published in:
- Anatolian Clinic Journal of Medical Sciences, 2023, v. 28, n. 1, p. 66, doi. 10.21673/anadoluklin.1135546
- By:
- Publication type:
- Article
Outcomes of Resectable Locally Advanced Non-Small Cell Lung Cancer After Neoadjuvant Chemoimmunotherapy: A Single Institution Experience.
- Published in:
- Journal of Clinical Medicine, 2025, v. 14, n. 3, p. 988, doi. 10.3390/jcm14030988
- By:
- Publication type:
- Article
Outcomes of Bridging Therapy in Liver Transplantation for Hepatocellular Carcinoma.
- Published in:
- Journal of Clinical Medicine, 2024, v. 13, n. 22, p. 6633, doi. 10.3390/jcm13226633
- By:
- Publication type:
- Article
Increased Pathologic Downstaging with Induction versus Consolidation Chemotherapy in Patients with Locally Advanced Rectal Cancer Treated with Total Neoadjuvant Therapy—A National Cancer Database Analysis.
- Published in:
- Journal of Clinical Medicine, 2024, v. 13, n. 3, p. 781, doi. 10.3390/jcm13030781
- By:
- Publication type:
- Article
Stage IV renal cell carcinoma achieves pathologic complete response after two ipilimumab plus nivolumab courses despite severe immune-related adverse events: a case report.
- Published in:
- Journal of Pharmaceutical Health Care & Sciences, 2024, v. 10, n. 1, p. 1, doi. 10.1186/s40780-024-00348-8
- By:
- Publication type:
- Article
HIV cure: Are we going to make history?
- Published in:
- HIV Medicine, 2024, v. 25, n. 3, p. 322, doi. 10.1111/hiv.13557
- By:
- Publication type:
- Article
Adjuvant and neoadjuvant therapy with or without CDK4/6 inhibitors in HR+/HER2- early breast cancer: a systematic review and meta-analysis.
- Published in:
- Frontiers in Pharmacology, 2024, p. 1, doi. 10.3389/fphar.2024.1438288
- By:
- Publication type:
- Article
Neoadjuvant immune checkpoint blockade in women with mismatch repair deficient endometrial cancer: a phase I study.
- Published in:
- Nature Communications, 2024, v. 15, n. 1, p. 1, doi. 10.1038/s41467-024-52098-8
- By:
- Publication type:
- Article
Bispecific Antibody Columvi Offering Option in Diffuse Large B-cell Lymphoma Treatment.
- Published in:
- American Health & Drug Benefits, 2024, v. 17, p. 13
- By:
- Publication type:
- Article
Neoadjuvant Chemotherapy in Patients with HER2- Negative Breast Cancer: A Report from Clinical Breast Cancer Registry of Iran.
- Published in:
- Archives of Iranian Medicine (AIM), 2024, v. 27, n. 4, p. 206, doi. 10.34172/aim.2024.30
- By:
- Publication type:
- Article
The Impact of Neoadjuvant Chemotherapy on Breast Cancer.
- Published in:
- Egyptian Journal of Hospital Medicine, 2024, v. 97, n. 1, p. 4027, doi. 10.21608/ejhm.2024.392209
- By:
- Publication type:
- Article
Association between physical activity and neoadjuvant chemotherapy completion and pathologic complete response in primary breast cancer: the CANTO study.
- Published in:
- 2022
- By:
- Publication type:
- journal article
RE104 aims to become the first psychedelic to treat postpartum depression.
- Published in:
- Contemporary OB/GYN, 2024, v. 69, n. 6, p. 16
- By:
- Publication type:
- Article
Prediction of therapy response of breast cancer patients with machine learning based on clinical data and imaging data derived from breast [<sup>18</sup>F]FDG-PET/MRI.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2024, v. 51, n. 5, p. 1451, doi. 10.1007/s00259-023-06513-9
- By:
- Publication type:
- Article
Development and validation of a gene expression-based Breast Cancer Purity Score.
- Published in:
- NPJ Precision Oncology, 2024, v. 8, n. 1, p. 1, doi. 10.1038/s41698-024-00730-7
- By:
- Publication type:
- Article
A phenocopy signature of TP53 loss predicts response to chemotherapy.
- Published in:
- NPJ Precision Oncology, 2024, v. 8, n. 1, p. 1, doi. 10.1038/s41698-024-00722-7
- By:
- Publication type:
- Article
Impact of intra‐tumoral immunity on predicting response and survival after neoadjuvant cisplatin‐based chemotherapy in patients with muscle invasive bladder cancer.
- Published in:
- Cancer Medicine, 2024, v. 13, n. 15, p. 1, doi. 10.1002/cam4.70088
- By:
- Publication type:
- Article
PD‐1 blockade enhances the effect of targeted chemotherapy on locally advanced pMMR/MSS colorectal cancer.
- Published in:
- Cancer Medicine, 2024, v. 13, n. 12, p. 1, doi. 10.1002/cam4.7224
- By:
- Publication type:
- Article
A dynamic nomogram for predicting pathologic complete response to neoadjuvant chemotherapy in locally advanced rectal cancer.
- Published in:
- Cancer Medicine, 2024, v. 13, n. 11, p. 1, doi. 10.1002/cam4.7251
- By:
- Publication type:
- Article
Nomogram for predicting pathologic complete response to neoadjuvant chemoradiotherapy in patients with esophageal squamous cell carcinoma.
- Published in:
- Cancer Medicine, 2024, v. 13, n. 5, p. 1, doi. 10.1002/cam4.7075
- By:
- Publication type:
- Article
Pathologic complete response in patients with esophageal cancer receiving neoadjuvant chemotherapy or chemoradiation: A systematic review and meta‐analysis.
- Published in:
- Cancer Medicine, 2024, v. 13, n. 4, p. 1, doi. 10.1002/cam4.7076
- By:
- Publication type:
- Article
Neoadjuvant chemotherapy for breast cancer: Pathologic response rates but not tumor size, has an independent prognostic impact on survival.
- Published in:
- Cancer Medicine, 2024, v. 13, n. 3, p. 1, doi. 10.1002/cam4.6930
- By:
- Publication type:
- Article
Anaemia and pathologic complete response rate according to carboplatin dose in HER2+ breast cancer treated with neoadjuvant TCHP.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 2, p. 1409, doi. 10.1002/cam4.5022
- By:
- Publication type:
- Article
Axillary Pathologic Complete Response After Neoadjuvant Systemic Therapy by Breast Cancer Subtype in Patients With Initially Clinically Node-Positive Disease: A Systematic Review and Meta-analysis.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Hot issues in triple-negative breast cancer.
- Published in:
- Cancer Biology & Medicine, 2023, v. 20, n. 12, p. 981, doi. 10.20892/j.issn.2095-3941.2023.0294
- By:
- Publication type:
- Article
Complete pathologic response in esophageal adenocarcinoma: does it make a difference?
- Published in:
- Diseases of the Esophagus, 2024, v. 37, n. 12, p. 1, doi. 10.1093/dote/doae068
- By:
- Publication type:
- Article